A somewhat arbitrary distinction is drawn between them based on the relative degree of marrow and nodal involvement and the numbers of circulating lymphoma cells. This lymphoma is very indolent but relentless, with median survivals of almost a decade. Although the slowly proliferating cells are sensitive to chemotherapeutic agents, chemotherapy is almost never curative and relapse inevitably follows.
Most studies find no benefit in treating patients until they develop symptoms.
A new and promising drug is fludarabine, but it has not been shown to prolong survival. Adult Patient and Health Professional Information Childhood Patient and Health Professional Info Frontiers in Bioscience is a source of B-cell information. This page is a work in progress - if you have more complete information, references, or other information please contact the author . The author is not in the medical field and does not warrant the correctness of the material on this page or the sites linked - please take online information and consult with your own medical team to make informed decisions.